<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteWyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Fri, 24 Jul 2026 19:33:48 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.5</generator>

		<!-- Start loop -->
		
			<item>
				<title>Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/</link>
        <pubDate>Wed, 22 Jul 2026 14:03:23 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Michael Levin]]></category>
		<category><![CDATA[Scientific Instrumentation Program]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45816</guid>
                            <description>Award enables unprecedented instrument capabilities at the Institute, facilitating collaborative research across many areas of human and environmental health</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next&#x2d;generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute is&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/</link>
          <title>During the MLSC’s award ceremony at the Wyss Institute, MLSC President and CEO Kirk Taylor (shown on this photo) and the MLSC team announced $19.7M in funding to support 23 projects, one of which is hosted by the Wyss Institute now. Credit: Massachusetts Life Science Center</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/21111648/MLSC-Wyss-Institute-Event-9063-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=379e9b74e7b11b351d0682acd4149e6f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Tackling cancer through riding and research</title>
				<link>https://wyss.harvard.edu/news/tackling-cancer-through-riding-and-research/</link>
        <pubDate>Mon, 20 Jul 2026 13:41:21 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45783</guid>
                            <description>A conversation with Ken Carlson and Jay Culverwell about how they’re addressing the Grand Challenge of cancer through their work and their participation in the Pan-Mass Challenge </description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff Imagine it&rsquo;s 5:50 AM on a Saturday morning in August. The sun&rsquo;s only been out for 20 minutes, but that hasn&rsquo;t stopped thousands of bicyclists and an equal number of volunteers from gathering in central Massachusetts. There&rsquo;s a feeling of anticipation as the clock keeps ticking, getting closer to 6:00 AM. Everyone is there for the same reason: to raise money for cancer research&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/tackling-cancer-through-riding-and-research/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/tackling-cancer-through-riding-and-research/</link>
          <title>Ken Carlson (left) and Jay Culverwell (right) will be participating in the 2026 Pan-Mass Challenge during the first weekend in August. Credit: Ken Carlson</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/16150009/IMG_8867-scaled.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b4bebed09a9500a8b16884cf33693b92"/></url>
				</image>
        			</item>

		
			<item>
				<title>Recapitulating intramuscular vaccination with mRNA vaccines in patient-specific Lymphoid Organ Chips</title>
				<link>https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/</link>
        <pubDate>Fri, 17 Jul 2026 13:55:40 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45749</guid>
                            <description>Expanded Lymphoid Organ Chip model captures mRNA vaccination from injection to protective antibody production with unprecedented complexity, with unique potential for mRNA vaccine research</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The protective abilities of the Moderna and BioNTech mRNA vaccines developed against COVID&#x2d;19 saved millions of lives during the pandemic and put this platform technology in the spotlight of vaccine research. By now, mRNA vaccines for other infectious diseases, such as influenza, RSV, and HIV are being tested in clinical trials and highly anticipated.</p>
<p><a href="https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/</link>
          <title>A cross-organizational research collaboration led by Wyss Director in Bioinspired Therapeutics Girija Goyal, Ph.D., and Wyss Founding Director and Bioinspired Therapeutics Lead Donald Ingber, M.D., Ph.D. has now developed an all-human alternative for evaluating vaccine-induced immunity with vast potential for guiding mRNA vaccine developments for multiple infectious diseases. Credit: Envato</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/15124540/adult-receives-an-injection-in-upper-arm-2026-03-25-01-13-28-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ac0ba85df94c5aeecfde0c64fe67c9ea"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2026-2027 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
        <pubDate>Mon, 06 Jul 2026 14:00:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Endometriosis]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45679</guid>
                            <description>From diagnostics and therapeutics to sustaining life on our planet, 16 Wyss teams are moving promising ideas closer to real-world impact</description>
                                        <content:encoded><![CDATA[<p>Each year, the Wyss Institute&rsquo;s Validation Project program identifies technologies that are ready to move beyond the discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de&#x2d;risk high&#x2d;impact&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
          <title>One Sarah's favorite things about the Wyss is being surrounded by others who are also trying to translate their technologies into companies. Here, she poses with a few of her entrepreneurial friends and colleagues. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/17153558/Sarah-and-Elizabeth-Candid-Neutral-07507-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bbbb793b3dc71fe4c18d05511384ed06"/></url>
				</image>
        			</item>

		
			<item>
				<title>Sarah Sandler on sailing towards a new solution for drug discovery</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/</link>
        <pubDate>Tue, 23 Jun 2026 15:27:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45589</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. In sailing and in science, it&rsquo;s important to communicate and stay calm in stressful situations, which is something postdoctoral fellow Sarah Sandler knows well. As a competitive sailor&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/</link>
          <title>Sarah Sandler, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/17131500/WoW-2026-Sarah-Sandler-Neutral-07439-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=0b67e28ea67f1225b578d0de47f600eb"/></url>
				</image>
        			</item>

		
			<item>
				<title>Machine-learning how to overcome antibiotic-resistant gonorrhea</title>
				<link>https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/</link>
        <pubDate>Wed, 17 Jun 2026 17:55:26 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45581</guid>
                            <description>AI-enabled antibiotic discovery proves effective at identifying new chemical structures and targets in the constant fight against antibiotic-resistant gonorrhea</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). In the U.S. alone, over 600,000 cases are reported each year. If left untreated, gonorrhea can result in severe reproductive health issues, including infertility in both women and men, and pelvic inflammatory disease.</p>
<p><a href="https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/</link>
          <title>Gonorrhea, which is caused by the bacterial pathogen Neisseria gonorrhoeae, is one of the most-often occurring sexually transmitted infections resulting in a plethora of health issues. Credit: Shutterstock/ESB Professional</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/16140539/shutterstock_1174971127-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=13990ec92c8d828d0baec3c7a1739c71"/></url>
				</image>
        			</item>

		
			<item>
				<title>David Chou on keeping people safe from radiation on Earth and beyond</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-david-chou-on-keeping-people-safe-from-radiation-on-earth-and-beyond/</link>
        <pubDate>Thu, 28 May 2026 13:00:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[BARDA]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[NASA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45523</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. David Chou&rsquo;s work is literally out of this world! In addition to identifying radiation countermeasures for use on Earth, he is part of the AVATAR project, which aims to understand how humans&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-david-chou-on-keeping-people-safe-from-radiation-on-earth-and-beyond/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-david-chou-on-keeping-people-safe-from-radiation-on-earth-and-beyond/</link>
          <title>Studying astronaut cells in Organ Chips will inform medical strategies for future long-duration missions to Mars and beyond. The findings could also contribute to biomedical advancements for patients on Earth, such as cancer treatments and pharmaceuticals. Credit: Wyss Institute at Harvard University.</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/04/08174412/NASA-Bonemarrow-Chips-03443_David-Chou-Holding-Chip-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bef790204e2d347f30adce2ce3c3d5a5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Destigmatizing mental health and democratizing brain-related research</title>
				<link>https://wyss.harvard.edu/news/destigmatizing-mental-health-and-democratizing-brain-related-research/</link>
        <pubDate>Wed, 27 May 2026 13:50:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Mental Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45501</guid>
                            <description>A conversation with Matthew Woodworth about mental health awareness and how his work on the CircaVent project will help improve the way we understand and treat mental health issues, like bipolar disorder</description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff More than one in five U.S. adults experience mental illness each year, but in 2024, only 52.1% of them received treatment. One reason people are reluctant to seek help is because of the stigma surrounding mental health. Often, that stigma comes from a lack of understanding and fear. Unfortunately, stigma doesn&rsquo;t only impact those with mental illnesses, but it also affects&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/destigmatizing-mental-health-and-democratizing-brain-related-research/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/destigmatizing-mental-health-and-democratizing-brain-related-research/</link>
          <title>Matthew Woodworth (right) with other CircaVent team members (left to right), Katharina Meyer, Jenny Tam, and Maria Gonçalves. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/20160645/Katharina-Jenny-Maria-and-Matt-Posed-Group-09708-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cf07a8104c9c8d6c9896db79f3746531"/></url>
				</image>
        			</item>

		
			<item>
				<title>Decoding inflammatory bowel disease – on a chip</title>
				<link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
        <pubDate>Thu, 21 May 2026 09:30:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45488</guid>
                            <description>Replication of patient- and sex-specific hallmarks of IBD in a human organ chip reveals stromal fibroblasts as drivers of inflammation, fibrosis, and enhanced cancer risk</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn&rsquo;s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/20121105/Colon-Chip.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c60ba1aa68dd5c86bf69c58c19a8c841"/></url>
				</image>
        			</item>

		
			<item>
				<title>Multidisciplinary Wyss team receives 2026 Lush Prize Science Award</title>
				<link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
        <pubDate>Mon, 18 May 2026 18:30:48 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45467</guid>
                            <description>Recognition highlights the growing impact of Organ Chip technology in reducing animal testing in biomedical and women’s health research</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next&#x2d;generation, sensor&#x2d;integrated human Organ&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
          <title>Wyss Research Scholar Zoheh Izadifar (left), a former Postdoctoral Fellow in the lab of Wyss Founding Director Donald Ingber, and now an Assistant Professor at Boston Children’s Hospital and Harvard Medical School, received the award on behalf of the Wyss teams during the Lush Prize award ceremony, held and livestreamed on May 12 in London. This photo shows her next to jury member Ellen Fritsche (right), Director of the Swiss Centre for Applied Human Toxicology (SCAHT) affiliated to the University of Basel. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/18113142/Zohreh-Izadifar-Science-LP26_Ellen-Fritsche-scaled-e1779118388548.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a7846fa4b4163e138d93bb0cd4969b75"/></url>
				</image>
        			</item>

			</channel>
</rss>
